Skip navigation

 Login or Register | Member Centre

GlobeInvestorGOLD Canada's most comprehensive investment tool.

Change Symbol: Lookup Trade Now

Lorus Therapeutics | Company Snapshot

  • Vol:
  • Last Trade:

LORUS THERAPEUTICS INC.

LORUS THERAPEUTICS INC. is a clinical stage drug development company targeting cancer. The Company focuses on novel and validated cancer targets using RNA-targeted and small molecule platform technologies.


Symbol: LOR
Exchange(s): Toronto Stock Exchange
Industry: Consumer Products (Biotechnology & Pharmaceuticals)
5-Star Rating:
ANNUAL FINANCIALS
  May 31, 2009
12 Months
C$
May 31, 2008
12 Months
C$
May 31, 2007
12 Months
C$
3Yr.
Growth
% Change
Total Revenue ($000): 454 585 610 4.31
Earnings before Interest & Tax ($000): -6,896 -10,428 -7,653 N/A
Profit/Loss ($000): -8,860 -6,334 -9,638 N/A
Earnings per Share: -0.04 -0.03 -0.05 N/A
Total Assets ($000): 7,527 11,607 15,475 -13.08
Dividends Per Share 0.00 0.00 0.00  
Return on Com. Equity: N/A N/A N/A  
Employees: N/A 35 33  
 
Trailing 12 Month Results
  12 Months ended
Aug 31, 2009, C$
12 Months ended
Aug 31, 2008, C$
%Change
Total Revenue ($000): 429 504 -14.88
Profit/Loss ($000): 3,112 -12,753 124.40
Earnings per Share: 0.01 -0.06 116.67
Dividends Per Share 0.00 0.00
Number of Shares: 257,010,000 248,226,000
 
COMPANY INFORMATION
Report on Business Magazine Top 1000 Ranking
Profit:  0 Revenue:  0 Assets:   0  
 
Key Personnel
CEO: Aiping Young, President & C.E.O.
CFO: Elizabeth Williams, Director of Finance
HR: Gloria Knight, HR Manager
 
Contact Information
Address: 2 Meridian Rd.,
Toronto,
ON,
M9W 4Z7
Phone: 416-798-1200
Fax: 416-798-2200
Web Address: www.lorusthera.com
E-Mail : info@lorusthera.com
Investor
Relations:
Saeid Babaei (Ext. 490), 416-798-1200
 
Company Type: Public Company Status: Active
Auditors: Kpmg Llp
Transfer Agent: Computershare Investor Service
Incorporation: Ontario, Sep 5, 1986
 
Securities: LOR-T
 
Top Companies in Biotechnology & Pharmaceuticals (Selected by Assets)
Biovail Patheon Inc. Atrium Innovations
QLT Inc. Angiotech Pharmaceuticals Cangene Corp.
Futuremed Healthcare Paladin Labs Inc LAB Research
 


All information on this site is compiled by CTVglobemedia Publishing Inc. from reliable industry sources. While all efforts are made to ensure the accuracy of the information, CTVglobemedia Publishing Inc. and its related entities assume no liability for incorrect, incomplete, or missing information from this site. Past performance is not necessarily indicative of future performance. Prior to making any investment decision, consult with a qualified investment advisor.

Copyright © 2009 CTVglobemedia Publishing Inc. All rights reserved.


Back to top